Oct 17 (Reuters) - Mesoblast MSB.AX :
* CO & LONZA ENTER AGREEMENT FOR COMMERCIAL MANUFACTURE OF MESOBLAST'S POTENTIAL FIRST UNITED STATES ALLOGENEIC CELL THERAPY
* EXPECTS TO COMPLETE FILING OF ROLLING BIOLOGICS LICENSE APPLICATION SUBMISSION TO US FDA BY THE END OF THIS YEAR